Essex LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Essex LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,430	Closed	-$967K	–	175
2024 Q2	$967K	Sell	10,430 -435	-4%	-$39K	0.22%	79
2024 Q1	$1.03M	Sell	10,865 -1,122	-9%	-$104K	0.24%	77
2023 Q4	$1.07M	Sell	11,987 -7,122	-37%	-$529K	0.27%	77
2023 Q3	$1.4M	Sell	19,109 -7,318	-28%	-$585K	0.39%	64
2023 Q2	$2.2M	Sell	26,427 -3,887	-13%	-$325K	0.61%	47
2023 Q1	$2.52M	Hold	30,314	–	–	0.76%	43
2022 Q4	$2.52M	Sell	30,314 -5	-0%	-$405	0.76%	43
2022 Q3	$2.4M	Buy	30,319 +5,541	+22%	+$467K	0.79%	44
2022 Q2	$1.84M	Sell	24,778 -822	-3%	-$61.7K	0.57%	58
2022 Q1	$2.3M	Buy	25,600 +2,026	+9%	+$187K	0.62%	52
2021 Q4	$2.64M	Buy	23,574 +1,970	+9%	+$238K	0.71%	46
2021 Q3	$2.72M	Buy	+21,604	New	+$2.78M	0.75%	45

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Essex LLC's XBI Position: Q3 2024 in Review

Essex LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 10,430 shares — an estimated $967K sold.

Essex LLC first reported a position in XBI in Q3 2021 and held it in 12 quarters. The position peaked at $2.72M in Q3 2021. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Essex LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
Essex LLC sold 10,430 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $967K.
Essex LLC first reported a position in State Street SPDR S&P Biotech ETF in Q3 2021 and held it in 12 quarters.
Essex LLC's State Street SPDR S&P Biotech ETF position peaked at $2.72M in Q3 2021.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Essex LLC's 13F filing for Q3 2024, filed 18 Oct 2024.